Table 3

Summary of complications of balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension and comparison between high-volume (performing more than 50 BPA sessions) and general institutions performing BPA sessions

Year2015201620172018Total
Number of institutions30424850120
Sessions4794677148522512
Complication (%) *10 (2.1)30 (6.4)45 (6.3)49 (5.8)134 (5.3)
 95% CI (%)1.0–3.84.4–9.04.6–8.34.3–7.5
 In-hospital death (%)1 (0.2)2 (0.4)1 (0.1)0 (0.0)4 (0.2)
 Required blood transfusion (%)3 (0.6)2 (0.4)2 (0.3)2 (0.2)9 (0.4)
 Emergent surgical treatment (%)1 (0.2)0 (0.0)0 (0.0)0 (0.0)1 (0.0)
 Distal embolism (%)1 (0.2)0 (0.0)0 (0.0)0 (0.0)1 (0.0)
 Vessel rupture (%)5 (1.0)6 (1.3)6 (0.8)6 (0.7)23 (0.9)
 Acute obstruction (%)1 (0.2)0 (0.0)0 (0.0)0 (0.0)1 (0.0)
 Contrast-induced nephropathy (%)1 (0.2)0 (0.0)1 (0.1)0 (0.0)2 (0.1)
 Others (%)7 (1.5)23 (4.9)37 (5.2)42 (4.9)109 (4.3)
  ‘Bloody sputum’ or ‘lung bleeding’3 (0.6)20 (4.2)29 (4.1)25 (2.9)77 (3.0)
 Cardiac shock required mechanical supportNo dataNo dataNo data0 (0.0)0 (0.0)
Number of facilities
 High volume (%)2 (6.7)2 (4.8)3 (6.3)6 (12.0)
 General (%)28 (93.3)40 (95.2)45 (93.7)44 (88.0)
Number of BPA session
 High volume (%)229 (47.8)151 (32.3)249 (34.9)451 (52.9)
 General (%)250 (52.2)316 (67.7)465 (65.1)401 (47.1)
Incidence of complications (%)
 High volume0.96.010.46.76.2
 General3.26.64.14.74.7
 P value0.140.940.0020.290.11
  • *p = 0.017

  • BPA, balloon pulmonary angioplasty.